Shows & Panels
Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- American Readiness: Renewable Power and Efficiency Technologies
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal News Radio's National Cyber Security Awareness Month Special Panel Discussion
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- Government Perspectives on Mobility and the Cloud
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Mitigating Insider Threats in Virtual & Cloud Environments
- Modern Mission Critical Series
- The New Generation of Database
- Reimagining the Next Generation of Government
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
Analysis: White House prescription drug proposal could mean fewer options
Tuesday - 10/25/2011, 5:14pm EDT
The deficit reduction supercommittee is considering a White House proposal to allow the Office of Personnel Management to negotiate directly with drug manufacturers.
Currently, OPM contracts with pharmacy benefits managers who negotiate drug prices. The administration said the change proposed in its letter to the supercommittee would offer lower prescription drug prices to federal employees and save the government $1.6 billion over the next decade.
But, in an interview with In Depth with Francis Rose, Robert Moffit, senior fellow at the Heritage Foundation's Center for Policy Innovation, said the White House's projected savings are a "very, very strange number."
In its proposal to the supercommittee, the White House said FEHBP pays $40 billion per year for health coverage and drugs represent 30 percent. Over the next decade, drugs would cost $120 billion, so the $1.6 billion savings is a mere 2 percent of drug expenditures, Moffit pointed out.
Lower costs for feds will also mean less options, he said.
"What you've got to worry about is OPM cracking down on the drugs that are available to you in order to get savings," Moffit said.
He said his concern is the OPM's negotiations would then become a larger issue of "congressional micro-management."
For now, the details of how the administration's proposal would work are not clear. The letter to the supercommittee only contains one paragraph on the proposal.
The Congressional Spotlight is brought to you by United Technologies Corporation.